Taiwan Liposome Competitors and Similar CompaniesClear all
Taiwan Liposome's competitors and similar companies include Mycenax Biotech, Sanofi Genzyme, Genor Biopharma and Roivant Sciences.
 Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Mycenax Biotech Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  Genor Biopharma Genor Biopharma is a company that manufactures antibodies and related biological products. | ||
Founding Date | Founding Date 1997 | Founding Date 2001 | Founding Date 1981 | Founding Date 2007 | Founding Date 2014 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Zhunan, TW HQ Taipei, TW Zhunan, TW | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations CN HQ | Locations London, GB HQ Basel, CH Boston, US New York, US |
Employees | Employees 1652% decrease | Employees 387 | Employees 9,9041% decrease | Employees 22245% decrease | Employees 908 |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) NT$740.2m (FY, 2025) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods NT$637.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit NT$129.8m (FY, 2020) | Gross profit NT$114.2m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (NT$983.3m) (FY, 2020) | Net income (NT$448.6m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($397.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 212m | Total funding raised $ 1.9b |
For sources of this data, please see the company profile
View Company Profiles
Mycenax Biotech
HQ
Zhunan, TW
Employees
387
Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyGenor Biopharma
HQ
CN
Employees
222↓ 45% decrease
Genor Biopharma is a company that manufactures antibodies and related biological products.
View company
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View company